太阳制药与武田制药签订协议，在印度商业化销售 Vonoprazan 片剂。
Sun Pharma inks agreement with Takeda Pharma for commercialising Vonoprazan tablets in India
作者： Capital Market
Sun Pharmaceutical Industries said that it has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company (Takeda) to commercialise Vonoprazan tablets in India under the brand name “Voltapraz”.
太阳制药工业公司表示，已与武田制药公司（武田）签订了非独家专利许可协议，以品牌名“Voltapraz”在印度商业化销售伏诺普拉赞片。
Sun Pharmaceutical Industries said that it has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company (Takeda) to commercialise Vonoprazan tablets in India under t… [+2286 chars]
太阳制药工业公司表示，已与武田制药公司（武田）签订非排他性专利许可协议，以在印度商业化Vonoprazan片剂。
原文链接：Business Standard